{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-222025-04-222025-04-232025-04-235121110108866442200
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-222025-04-222025-04-232025-04-232124110108866442200
Download SVG
Download PNG
Download CSV

nordea bank reports quarterly earnings miss with lower than expected eps

Nordea Bank Abp reported quarterly earnings of $0.34 per share, falling short of the $0.37 consensus estimate by $0.03. The bank's net margin stood at 19.28%, with a return on equity of 16.41%. Despite a trading volume of 152,821 shares, the stock price dipped to $12.20, reflecting a market cap of $42.73 billion and a PE ratio of 7.92.

FDM Group shares decline as Deutsche Bank cuts price target to 275 GBp

FDM Group shares (LON: FDM) have seen a significant decline, dropping 24.59% in early 2025 and 47.88% over the past year. Deutsche Bank has cut its price target from 360 GBp to 275 GBp while maintaining a Hold rating, reflecting cautious optimism amid a challenging market. The stock, currently trading at 239.50p, has fallen over 80% since September 2021, as it seeks support in a fluctuating environment.

european union sees increase in pig slaughter and stabilizing pork exports

Pork production in the EU saw a 1.2% increase in slaughtered pigs from January to October 2024 compared to the previous year, with notable growth in Central and Eastern Europe. Romania and Hungary reported increases of 7.4% and 6.9%, respectively, while Denmark and the Netherlands experienced declines. EU pork exports stabilized at 3.16 million tonnes by September 2024, with China and the UK as the top buyers.

nordea bank reports growth in net profit and operating income for fy24

Nordea Bank Abp reported growth in FY24, with attributable net profit and operating income reflecting its diverse banking services. The income distribution highlights personal banking at 38.9%, business banking at 29.2%, institutional and large corporate banking at 20.2%, and assets and wealth management at 11.7%. Geographically, income is sourced from Finland (24.9%), Sweden (27.3%), Denmark (26.5%), Norway (17.5%), and other regions (3.8%).

UBS maintains buy rating for Novo Nordisk with target price of 750 crowns

UBS has maintained a 'Buy' rating for Novo Nordisk, setting a target price of 750 Danish crowns ahead of the fourth quarter results. Analyst Jo Walton noted that expectations are low, with particular attention on the drugs CagriSema and Amycretin, as well as the company's future plans. Novo Nordisk has seen a remarkable 3,501% increase since its initial recommendation.

ubs rates novo nordisk as buy with investment risks highlighted

UBS has rated Novo Nordisk as a 'Buy', but this information is for informational purposes only and does not constitute a recommendation to buy or sell. Investing in securities carries risks, including the potential loss of the entire capital invested. Expert investment advice tailored to individual needs is recommended, as no liability for the accuracy or completeness of the information is assumed.

ubs lowers target price for orsted while maintaining buy rating

UBS has reduced its target price for Ørsted to DKK 460 from DKK 520 while maintaining a Buy rating. Ørsted, a leading Danish energy group, generates 72% of its net sales from offshore wind farms, producing 17.8 TWh of wind energy in 2023, with an installed capacity of 8.9 GW. The company also engages in electricity, gas, and bioenergy production, alongside developing onshore wind and solar PV farms.

ubs lowers orsted target price and reaffirms takeover offer

UBS has reduced its target price for Ørsted to 460 DKK from 520 DKK while reaffirming its takeover offer. Ørsted A/S, a leading Danish energy group, generates 72% of its sales from offshore wind farms, with 17.8 TWh produced in 2023, and has an installed capacity of 8.9 GW. The company also engages in electricity, gas, and bioenergy production, alongside developing onshore wind and solar farms.

ubs rates novo nordisk as buy amid investment considerations and risks

UBS has rated Novo Nordisk as a 'Buy', but the information provided is for informational purposes only and does not constitute a recommendation to buy or sell. Investing in securities carries risks, including the potential total loss of capital, and expert investment advice is recommended. No liability for the accuracy or completeness of the information is assumed, and the content is solely the responsibility of the authors, which may not reflect the views of wallstreetONLINE.

fifth edition of pigdays webinar series to address industry challenges and solutions

The fifth edition of Pigdays, a virtual event series by AGRAVIS and Topigs Norsvin, will commence on January 29, 2025, featuring expert-led seminars on the pig industry. Key topics include market trends, climate accounting in meat production, and AI in pig breeding and management. Participation is free, with registration available at www.pigdays.de.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.